This is a summary of the European public assessment report (EPAR) for Pregabalin Pfizer. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Pregabalin Pfizer. For practical information about using Pregabalin Pfizer, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Neuropathic pain - Pregabalin Pfizer is indicated for the treatment of peripheral and central neuropathic pain in adults. Epilepsy - Pregabalin Pfizer is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. Generalised Anxiety Disorder - Pregabalin Pfizer is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Therapeutic Area (MeSH)
N/AATC Code
N02BF02
ATC Item
pregabalin
Pharmacotherapeutic Group
Antiepileptics
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| pregabalin | N/A | 普瑞巴林 |
EMA Name
Pregabalin Pfizer
Medicine Name
Pregabalin Pfizer
Aliases
N/ANo risk management plan link.
